Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms
Description
Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient. MeSH
Hierarchy View
Subtype Terms (39)
Aging, Premature
3 drugs (2 approved, 1 experimental)
Asthenia
4 drugs (1 approved, 3 experimental)
Body Temperature Changes
8 drugs (6 approved, 2 experimental)
Body Weight
88 drugs (41 approved, 47 experimental)
Cardiac Output, High
3 approved drugs
Cardiac Output, Low
18 drugs (11 approved, 7 experimental)
Chills
3 approved drugs
Cyanosis
2 drugs (1 approved, 1 experimental)
Edema
80 drugs (57 approved, 23 experimental)
Eye Manifestations
1 approved drug
Failure to Thrive
2 approved drugs
Fatigue
155 drugs (84 approved, 71 experimental)
Fetal Distress
7 drugs (5 approved, 2 experimental)
Hot Flashes
74 drugs (44 approved, 30 experimental)
Hyperlactatemia
11 approved drugs
Hypertriglyceridemic Waist
1 approved drug
Intermittent Claudication
57 drugs (27 approved, 30 experimental)
Medically Unexplained Symptoms
1 approved drug
Mobility Limitation
13 drugs (10 approved, 3 experimental)
Motion Sickness
11 drugs (7 approved, 4 experimental)
Myocardial Stunning
12 drugs (9 approved, 3 experimental)
Neurologic Manifestations
18 drugs (14 approved, 4 experimental)
Oral Manifestations
6 drugs (4 approved, 2 experimental)
Prodromal Symptoms
1 approved drug
Pseudophakia
7 approved drugs
Renal Colic
34 drugs (24 approved, 10 experimental)
Signs and Symptoms, Digestive
15 drugs (6 approved, 9 experimental)
Signs and Symptoms, Respiratory
9 drugs (8 approved, 1 experimental)
Skin Manifestations
13 drugs (10 approved, 3 experimental)
Sleepiness
5 drugs (3 approved, 2 experimental)
Travel-Related Illness
1 experimental drug
Urological Manifestations
48 drugs (30 approved, 18 experimental)
Phase 4 Indicated Drugs (18)
Phase 3 Indicated Drugs (5)
Phase 2 Indicated Drugs (7)
Phase 1 Indicated Drugs (6)
Other Experimental Indicated Drugs (12)
Organization Involved with Phase 4 Indications (24)
Organization Involved with Phase 3 Indications (19)
Organization Involved with Phase 2 Indications (18)
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (19)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
